Zhang J, Wang Y, Liu H, Lei Z, Cheng S, Cao H
Front Nutr. 2025; 12:1498757.
PMID: 39963665
PMC: 11830586.
DOI: 10.3389/fnut.2025.1498757.
Hayama T, Ochiai H, Ozawa T, Miyata T, Asako K, Fukushima Y
Sci Rep. 2025; 15(1):1008.
PMID: 39762444
PMC: 11704263.
DOI: 10.1038/s41598-024-84991-z.
Ren Z, Xue Y, Zhang H, Guo T, Yi W, Li L
Int Dent J. 2024; 74(5):1033-1043.
PMID: 38688802
PMC: 11561492.
DOI: 10.1016/j.identj.2024.03.019.
Ding Y, Liu Z, Li J, Niu W, Li C, Yu B
BMC Surg. 2024; 24(1):89.
PMID: 38481180
PMC: 10935841.
DOI: 10.1186/s12893-024-02384-5.
Zheng C, Ye S, Liu W, Diao M, Li L
Front Oncol. 2023; 13:1276175.
PMID: 37901310
PMC: 10613067.
DOI: 10.3389/fonc.2023.1276175.
Association of inflammatory markers with all-cause mortality and cardiovascular mortality in postmenopausal women with osteoporosis or osteopenia.
Qu L, Zuo X, Yu J, Duan R, Zhao B
BMC Womens Health. 2023; 23(1):487.
PMID: 37705033
PMC: 10500848.
DOI: 10.1186/s12905-023-02631-6.
A predictive survival model for patients with stage IV oropharyngeal squamous cell carcinoma treated with chemoradiation.
Yeh P, Chang C, Liao L, Wu C, Hsieh C, Shueng P
Eur Arch Otorhinolaryngol. 2023; 281(1):369-377.
PMID: 37594545
DOI: 10.1007/s00405-023-08187-3.
A nomogram for distinguishing benign and malignant parotid gland tumors using clinical data and preoperative blood markers: development and validation.
Zhao F, Huang X, He J, Li J, Li Q, Wei F
J Cancer Res Clin Oncol. 2023; 149(13):11719-11733.
PMID: 37402966
DOI: 10.1007/s00432-023-05032-2.
Prognostic models for upper urinary tract urothelial carcinoma patients after radical nephroureterectomy based on a novel systemic immune-inflammation score with machine learning.
Liu J, Wu P, Lai S, Wang J, Hou H, Zhang Y
BMC Cancer. 2023; 23(1):574.
PMID: 37349696
PMC: 10286456.
DOI: 10.1186/s12885-023-11058-z.
An S-like curve relationship between systemic inflammation response index (SIRI) and respiratory failure in GBS patients.
Shen Q, Mu X, Bao Y, Xu F, Zhang D, Luo A
Neurol Sci. 2023; 44(9):3279-3285.
PMID: 37079126
DOI: 10.1007/s10072-023-06784-y.
Prognostic value of the systemic immune-inflammation index, systemic inflammation response index, and prognostic nutritional index in head and neck cancer.
Atasever Akkas E, Erdis E, Yucel B
Eur Arch Otorhinolaryngol. 2023; 280(8):3821-3830.
PMID: 37029321
DOI: 10.1007/s00405-023-07954-6.
Prognostic capacity of the systemic inflammation response index for functional outcome in patients with aneurysmal subarachnoid hemorrhage.
Hou Y, Fan J, Yuan H, Zheng H, Yang H, Li H
Front Neurol. 2023; 14:1054315.
PMID: 36937535
PMC: 10017774.
DOI: 10.3389/fneur.2023.1054315.
Neutrophil to Lymphocyte Ratio in Oropharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Rodrigo J, Sanchez-Canteli M, Triantafyllou A, de Bree R, Makitie A, Franchi A
Cancers (Basel). 2023; 15(3).
PMID: 36765760
PMC: 9913392.
DOI: 10.3390/cancers15030802.
The role of systemic inflammatory response index (SIRI) and tumor-infiltrating lymphocytes (TILs) in the prognosis of patients with laryngeal squamous cell carcinoma.
Wang T, Zhang D, Tang D, Heng Y, Lu L, Tao L
J Cancer Res Clin Oncol. 2022; 149(9):5627-5636.
PMID: 36520215
DOI: 10.1007/s00432-022-04469-1.
Evaluation of systemic inflammatory and nutritional indexes in locally advanced gastric cancer treated with adjuvant chemoradiotherapy after D2 dissection.
Wang S, Chen J, Xu C, Cao W, Cai R, Cao L
Front Oncol. 2022; 12:1040495.
PMID: 36387250
PMC: 9648693.
DOI: 10.3389/fonc.2022.1040495.
Prognostic implications of preoperative systemic inflammatory markers in oral squamous cell carcinoma, and correlations with the local immune tumor microenvironment.
Ruiz-Ranz M, Lequerica-Fernandez P, Rodriguez-Santamarta T, Suarez-Sanchez F, Lopez-Pintor R, Garcia-Pedrero J
Front Immunol. 2022; 13:941351.
PMID: 35958590
PMC: 9360320.
DOI: 10.3389/fimmu.2022.941351.
Association between Neutrophil-to-Lymphocyte Ratio and the Systemic Inflammatory Immunologic Index and the Angiographic SYNTAX Score and the TIMI Flow Grade in Acute STEMI: A Cohort Study.
Rostami A, Tajlil A, Separham A, Sohrabi B, Pourafkari L, Roshanravan N
J Tehran Heart Cent. 2022; 16(4):147-155.
PMID: 35935551
PMC: 9308885.
DOI: 10.18502/jthc.v16i4.8600.
Use of the systemic inflammation response index (SIRI) as a novel prognostic marker for patients on peritoneal dialysis.
Li J, Li Y, Zou Y, Chen Y, He L, Wang Y
Ren Fail. 2022; 44(1):1227-1235.
PMID: 35848372
PMC: 9297720.
DOI: 10.1080/0886022X.2022.2100262.
Serum Proteomics in Patients with Head and Neck Cancer: Peripheral Blood Immune Response to Treatment.
Astradsson T, Sellberg F, Tiblom Ehrsson Y, Sandstrom K, Laurell G
Int J Mol Sci. 2022; 23(11).
PMID: 35682983
PMC: 9180944.
DOI: 10.3390/ijms23116304.
A predictive model for advanced oropharyngeal cancer patients treated with chemoradiation.
Lo W, Chang C, Wu C, Hsieh C, Shueng P, Cheng P
BMC Cancer. 2022; 22(1):615.
PMID: 35659619
PMC: 9167527.
DOI: 10.1186/s12885-022-09732-9.
